Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Scottish Chemo-Endocrine Trial D
NCT00002579Phase 3Completed
- Sponsor
- Scottish Cancer Therapy Network
- Start
- Mar 1993
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tamoxifen in breast cancer (2 arms), sponsored by Scottish Cancer Therapy Network. Primary endpoints: Disease-Free Survival at 5 years and Overall Survival at 5 years. Started Mar 1993; status: completed.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00002579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002579.